OVB vs. TCF, EVG, MTFB, BSFA, ROQ, DEST, VAL, RENE, SALV, and OCTP
Should you be buying Ovoca Bio stock or one of its competitors? The main competitors of Ovoca Bio include Theracryf (TCF), Evgen Pharma (EVG), Motif Bio (MTFB), BSF Enterprise (BSFA), Roquefort Therapeutics (ROQ), Destiny Pharma (DEST), ValiRx (VAL), ReNeuron Group (RENE), SalvaRx Group (SALV), and Oxford Cannabinoid Technologies (OCTP). These companies are all part of the "biotechnology" industry.
Ovoca Bio vs.
Theracryf (LON:TCF) and Ovoca Bio (LON:OVB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.
Ovoca Bio has a net margin of 0.00% compared to Theracryf's net margin of -792.17%. Ovoca Bio's return on equity of -52.49% beat Theracryf's return on equity.
In the previous week, Theracryf's average media sentiment score of 0.00 equaled Ovoca Bio'saverage media sentiment score.
Ovoca Bio has lower revenue, but higher earnings than Theracryf. Ovoca Bio is trading at a lower price-to-earnings ratio than Theracryf, indicating that it is currently the more affordable of the two stocks.
Ovoca Bio received 17 more outperform votes than Theracryf when rated by MarketBeat users.
37.0% of Theracryf shares are held by institutional investors. 42.9% of Theracryf shares are held by company insiders. Comparatively, 44.7% of Ovoca Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Theracryf has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Comparatively, Ovoca Bio has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500.
Summary
Ovoca Bio beats Theracryf on 6 of the 11 factors compared between the two stocks.
Get Ovoca Bio News Delivered to You Automatically
Sign up to receive the latest news and ratings for OVB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ovoca Bio Competitors List
Related Companies and Tools
This page (LON:OVB) was last updated on 2/23/2025 by MarketBeat.com Staff
